Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
HeartSciences reported a $3.2 million net loss for its fiscal first quarter ended July 31, 2026, with no meaningful revenue. Loss from operations was $2.9 million, including a $0.3 million inventory reserve tied to its wavECG device.
HeartSciences reported FQ1 2027 net loss of $3.2M vs $2.1M and no meaningful revenue. The Fortitude merger is expected to close in Q4 2026, subject to conditions.Material DetailsContext by AI AnalystThis is early-stage confirmation of ongoing losses while pivoting to a software platform and pursuin…